IL109770D0 - Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release solid dosage forms of medicaments prepared thereby - Google Patents

Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release solid dosage forms of medicaments prepared thereby

Info

Publication number
IL109770D0
IL109770D0 IL10977094A IL10977094A IL109770D0 IL 109770 D0 IL109770 D0 IL 109770D0 IL 10977094 A IL10977094 A IL 10977094A IL 10977094 A IL10977094 A IL 10977094A IL 109770 D0 IL109770 D0 IL 109770D0
Authority
IL
Israel
Prior art keywords
dosage forms
controlled release
solid dosage
medicaments
release solid
Prior art date
Application number
IL10977094A
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB939311188A priority Critical patent/GB9311188D0/en
Priority to GB939316252A priority patent/GB9316252D0/en
Priority to GB939318920A priority patent/GB9318920D0/en
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of IL109770D0 publication Critical patent/IL109770D0/en

Links

IL10977094A 1993-05-29 1994-05-25 Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release solid dosage forms of medicaments prepared thereby IL109770D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB939311188A GB9311188D0 (en) 1993-05-29 1993-05-29 Process
GB939316252A GB9316252D0 (en) 1993-08-05 1993-08-05 Process
GB939318920A GB9318920D0 (en) 1993-09-11 1993-09-11 Process

Publications (1)

Publication Number Publication Date
IL109770D0 true IL109770D0 (en) 1994-11-28

Family

ID=27266706

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10977094A IL109770D0 (en) 1993-05-29 1994-05-25 Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release solid dosage forms of medicaments prepared thereby

Country Status (12)

Country Link
EP (1) EP0701436B1 (en)
JP (1) JPH08510752A (en)
AP (1) AP9400645A0 (en)
AT (1) AT230981T (en)
AU (1) AU684522B2 (en)
CA (1) CA2164003A1 (en)
DE (2) DE69432015D1 (en)
ES (1) ES2189803T3 (en)
IL (1) IL109770D0 (en)
MA (1) MA23212A1 (en)
NZ (1) NZ268172A (en)
WO (1) WO1994027557A2 (en)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9402203D0 (en) * 1994-02-04 1994-03-30 Smithkline Beecham Plc Pharmaceutical formulation
GB9407386D0 (en) 1994-04-14 1994-06-08 Smithkline Beecham Plc Pharmaceutical formulation
GB9416600D0 (en) * 1994-08-17 1994-10-12 Smithkline Beecham Plc Pharmaceutical formulation
DE69617036T2 (en) * 1995-09-07 2002-07-11 Smithkline Beecham Corp Use of a amoxicillin and clavulanate containing pediatric pharmaceutical formulation
TWI225402B (en) 1996-03-13 2004-12-21 Biochemie Gmbh Auxiliary-free agglomerates
AT407701B (en) * 1996-08-12 2001-05-25 Biochemie Gmbh Mixture which is suitable for direct tableting and contains as essential components amoxicillin trihydrate and the calcium salt of clavulanic acid, and process for preparing this mixture
FR2753904B1 (en) 1996-10-01 1998-10-30 Gattefosse Ets Sa A pharmaceutical composition with modified release of active ingredient comprising a matrix and method for making
IL119627A (en) * 1996-11-17 2002-03-10 Yissum Res Dev Co PHARMACEUTICAL PREPARATIONS FOR THE CONTROLLED-RELEASE OF AN ACTIVE AGENT COMPRISING AT LEAST ONE β-LACTAM ANTIBIOTIC AGENT
DE19705538C1 (en) * 1997-02-14 1998-08-27 Goedecke Ag Process for the separation of active ingredients in solid pharmaceutical preparations
CN1194687C (en) * 1997-02-14 2005-03-30 史密斯克莱恩比彻姆药物实验室 Pharmaceutical formulations comprising amoxocyllin and clavulanate
CA2302275C (en) * 1997-09-19 2009-12-08 Shire Laboratories Inc. Solid solution beadlet
US6365196B1 (en) * 1997-10-03 2002-04-02 Smithkline Beecham Corporation Controlled release solid dosage forms of lithium carbonate
JP2001516365A (en) * 1997-11-17 2001-09-25 ギスト ブロカデス ベスローテン フェンノートシャップ Granules comprising clavulanate and one or more excipients
DK1041987T3 (en) * 1997-12-22 2006-08-21 Euro Celtique Sa An oral pharmaceutical dosage form comprising a combination of an opioid agonist and naltrexone
BR9908911A (en) 1998-03-19 2001-10-02 Squibb Bristol Myers Co biphasic system and distribution process by controlled release of high solubility pharmaceutical substances
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
CO5170471A1 (en) * 1999-04-13 2002-06-27 Beecham Pharmaceutical Pte Ltd Modified release tablets including amoxycillin and potassium clavulanate
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6627222B2 (en) 2000-02-24 2003-09-30 Advancis Pharmaceutical Corp. Amoxicillin-dicloxacillin antibiotic composition
US6991807B2 (en) 2000-02-24 2006-01-31 Advancis Pharmaceutical, Corp. Antibiotic composition
EP1267765A4 (en) 2000-02-24 2008-12-24 Middlebrook Pharmaceuticals In Antibiotic and antifungal compositions
US6610328B2 (en) 2000-02-24 2003-08-26 Advancis Pharmaceutical Corp. Amoxicillin-clarithromycin antibiotic composition
US6667042B2 (en) 2000-02-24 2003-12-23 Advancis Pharmaceutical Corp. Fluroquinilone antibiotic product, use and formulation thereof
US7105174B2 (en) 2000-10-13 2006-09-12 Advancis Pharmaceutical Corporation Multiple-delayed release anti-neoplastic product, use and formulation thereof
US7025989B2 (en) 2000-02-24 2006-04-11 Advancis Pharmaceutical Corp. Multiple-delayed released antibiotic product, use and formulation thereof
US6632453B2 (en) 2000-02-24 2003-10-14 Advancis Pharmaceutical Corp. Ciprofoxacin-metronidazole antibiotic composition
US6669948B2 (en) 2000-02-24 2003-12-30 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6623758B2 (en) 2000-02-24 2003-09-23 Advancis Pharmaceutical Corp. Cephalosporin-metronidazole antibiotic composition
US6663890B2 (en) 2000-02-24 2003-12-16 Advancis Pharmaceutical Corp. Metronidazole antibiotic product, use and formulation thereof
US6565882B2 (en) 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6667057B2 (en) 2000-02-24 2003-12-23 Advancis Pharmaceutical Corp. Levofloxacin antibiotic product, use and formulation thereof
US6730320B2 (en) 2000-02-24 2004-05-04 Advancis Pharmaceutical Corp. Tetracycline antibiotic product, use and formulation thereof
US6663891B2 (en) 2000-02-24 2003-12-16 Advancis Pharmaceutical Corp. Erythromyacin antibiotic product, use and formulation thereof
AU3986901A (en) * 2000-02-24 2001-09-03 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
WO2002030392A2 (en) 2000-10-12 2002-04-18 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
US7157095B2 (en) 2000-10-13 2007-01-02 Advancis Pharmaceutical Corporation Multiple-delayed release antifungal product, use and formulation thereof
US7074417B2 (en) 2000-10-13 2006-07-11 Advancis Pharmaceutical Corporation Multiple-delayed release anti-viral product, use and formulation thereof
US6541014B2 (en) 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020197314A1 (en) 2001-02-23 2002-12-26 Rudnic Edward M. Anti-fungal composition
AT413015B (en) * 2001-04-12 2005-10-15 Sandoz Ag Pharmaceutical composition useful for reducing rapid degradation of the active ingredient comprises clavulanate, in the form of granulated and hydrophobised particles, and an active ingredient
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
JP2006514672A (en) * 2003-03-04 2006-05-11 ノストラム・ファーマスーティカルズ・インコーポレイテッド Controlled release formulations containing a hydrophobic substance as a sustained release agent
WO2005016278A2 (en) 2003-08-12 2005-02-24 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
WO2005053653A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Spray-congeal process using an extruder for preparing multiparticulate azithromycin compositions containing preferably a poloxamer and a glyceride
ES2600577T3 (en) * 2003-12-04 2017-02-09 Bend Research, Inc. Spray-solidification method using an extruder to prepare compositions in multiparticulate crystalline drugs
AR050615A1 (en) * 2004-08-27 2006-11-08 Novartis Ag Pharmaceutical compositions for oral administration
KR101214665B1 (en) 2004-09-16 2012-12-21 아스텔라스세이야쿠 가부시키가이샤 Triazole derivatives or salts thereof
JP6042330B2 (en) 2010-07-09 2016-12-14 ビーエイチヴィ ファーマ、インコーポレイテッド Combinations immediate / delayed release delivery systems for a short half-life pharmaceuticals including Remogurifurojin
GB201420311D0 (en) * 2014-11-14 2014-12-31 Bio Images Drug Delivery Ltd Pharmaceutical processing

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132753A (en) * 1965-02-12 1979-01-02 American Cyanamid Company Process for preparing oral sustained release granules
JPS56140915A (en) * 1980-04-07 1981-11-04 Yamanouchi Pharmaceut Co Ltd Pharmaceutical preparation for solid drug
US5169645A (en) * 1989-10-31 1992-12-08 Duquesne University Of The Holy Ghost Directly compressible granules having improved flow properties

Also Published As

Publication number Publication date
MA23212A1 (en) 1994-12-31
AU684522B2 (en) 1997-12-18
EP0701436A4 (en) 1997-05-21
EP0701436B1 (en) 2003-01-15
JPH08510752A (en) 1996-11-12
DE69432015D1 (en) 2003-02-20
WO1994027557A3 (en) 1995-03-16
NZ268172A (en) 1997-12-19
AP9400645A0 (en) 1994-07-31
ES2189803T3 (en) 2003-07-16
DE69432015T2 (en) 2003-11-06
EP0701436A1 (en) 1996-03-20
WO1994027557A2 (en) 1994-12-08
AT230981T (en) 2003-02-15
CA2164003A1 (en) 1994-12-08
AU7096294A (en) 1994-12-20

Similar Documents

Publication Publication Date Title
GB2257973B (en) A composition for the sustained and controlled release of medicamentous substances and a process for preparing the same
GB2245492B (en) Programmed release oral solid pharmaceutical dosage form
AR243382A1 (en) Intravenous pharmaceutical composition and process for preparing the same
AU632859B2 (en) Dosage form for administering oral hypoglycemic glipizide
GB2199031B (en) Cyclodextrinclathrates of carbacycline derivatives and their use as medicinal drugs
LTIP656A (en) Derivatives of 3-amidopyrazole, process for preparing thereof and pharmaceutical composition containing them
AU3227389A (en) Controlled release pharmaceutical preparation and method for producing the same
HUT56267A (en) Process for producing pharmaceutical compositions having controlled release of active ingredient
ZA9102711B (en) Device for the administration of powdered medicinal substances
ZA9508073B (en) Method of and apparatus for administering a drug to a patient
KR100206481B1 (en) Galenic form for ocular administration and process for the preparation of same
HU9400255D0 (en) Process for producing benzimidazole derivatives and pharmaceutical preparations containing them
HUT50046A (en) Process for producing pharmaceutical compositions with controlled release and comprising tetracycline compounds
IL86053D0 (en) Rapidly dissoluble medicinal dosage unit and its manufacture
CZ278971B6 (en) Pharmaceutical mixture for intravaginal administration
JPS63260572A (en) Apparatus for administration of aerosol drug
IL78826D0 (en) Sustained release pharmaceutical compositions incorporating degradable delivery system of drugs
IL115646D0 (en) Medicinal and/or nutritional microcapsules for oral administration
EP0224146A3 (en) Pharmaceutical preparation for the controlled release of active ingredients
CZ9401937A3 (en) Pharmaceutical preparation of human insulin
CZ9703655A3 (en) Three-phase pharmaceutical form with constant and controlled release of amorphous active component for single daily administration
PL265417A1 (en) Pharmaceutical preparations for oral administration and a method of their production
NZ227032A (en) Stabilised ace inhibitors, a process for their preparation and stable pharmaceutical compositions therefrom
EP0268956A3 (en) Pyridine derivatives, pharmaceutical compositions comprising the same, the use of the same for the manufacture of medicaments having therapeutic or preventative value, and a process for preparing the same
AU7581391A (en) Dosage form for delivering drug to the intestine